Cargando…
High‐Performance Liquid Chromatography Method for Rich Pharmacokinetic Sampling Schemes in Translational Rat Toxicity Models With Vancomycin
A translational need exists to understand and predict vancomycin‐induced kidney toxicity. We describe: (i) a vancomycin high‐performance liquid chromatography (HPLC) method for rat plasma and kidney tissue homogenate; (ii) a rat pharmacokinetic (PK) study to demonstrate utility; and (iii) a catheter...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698807/ https://www.ncbi.nlm.nih.gov/pubmed/28675684 http://dx.doi.org/10.1111/cts.12484 |
_version_ | 1783280831258689536 |
---|---|
author | Joshi, MD O'Donnell, JN Venkatesan, N Chang, J Nguyen, H Rhodes, NJ Pais, G Chapman, RL Griffin, B Scheetz, MH |
author_facet | Joshi, MD O'Donnell, JN Venkatesan, N Chang, J Nguyen, H Rhodes, NJ Pais, G Chapman, RL Griffin, B Scheetz, MH |
author_sort | Joshi, MD |
collection | PubMed |
description | A translational need exists to understand and predict vancomycin‐induced kidney toxicity. We describe: (i) a vancomycin high‐performance liquid chromatography (HPLC) method for rat plasma and kidney tissue homogenate; (ii) a rat pharmacokinetic (PK) study to demonstrate utility; and (iii) a catheter retention study to enable future preclinical studies. Rat plasma and pup kidney tissue homogenate were analyzed via HPLC for vancomycin concentrations ranging from 3–75 and 15.1–75.5 μg/mL, respectively, using a Kinetex Biphenyl column and gradient elution of water with 0.1% formic acid: acetonitrile (70:30 v/v). Sprague‐Dawley rats (n = 10) receiving 150 mg/kg of vancomycin intraperitoneally had plasma sampled for PK. Finally, a catheter retention study was performed on polyurethane catheters to assess adsorption. Precision was <6.1% for all intra‐assay and interassay HPLC measurements, with >96.3% analyte recovery. A two‐compartment model fit the data well, facilitating PK exposure estimates. Finally, vancomycin was heterogeneously retained by polyurethane catheters. |
format | Online Article Text |
id | pubmed-5698807 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-56988072017-11-30 High‐Performance Liquid Chromatography Method for Rich Pharmacokinetic Sampling Schemes in Translational Rat Toxicity Models With Vancomycin Joshi, MD O'Donnell, JN Venkatesan, N Chang, J Nguyen, H Rhodes, NJ Pais, G Chapman, RL Griffin, B Scheetz, MH Clin Transl Sci Research A translational need exists to understand and predict vancomycin‐induced kidney toxicity. We describe: (i) a vancomycin high‐performance liquid chromatography (HPLC) method for rat plasma and kidney tissue homogenate; (ii) a rat pharmacokinetic (PK) study to demonstrate utility; and (iii) a catheter retention study to enable future preclinical studies. Rat plasma and pup kidney tissue homogenate were analyzed via HPLC for vancomycin concentrations ranging from 3–75 and 15.1–75.5 μg/mL, respectively, using a Kinetex Biphenyl column and gradient elution of water with 0.1% formic acid: acetonitrile (70:30 v/v). Sprague‐Dawley rats (n = 10) receiving 150 mg/kg of vancomycin intraperitoneally had plasma sampled for PK. Finally, a catheter retention study was performed on polyurethane catheters to assess adsorption. Precision was <6.1% for all intra‐assay and interassay HPLC measurements, with >96.3% analyte recovery. A two‐compartment model fit the data well, facilitating PK exposure estimates. Finally, vancomycin was heterogeneously retained by polyurethane catheters. John Wiley and Sons Inc. 2017-07-04 2017-11 /pmc/articles/PMC5698807/ /pubmed/28675684 http://dx.doi.org/10.1111/cts.12484 Text en © 2017 The Authors. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Research Joshi, MD O'Donnell, JN Venkatesan, N Chang, J Nguyen, H Rhodes, NJ Pais, G Chapman, RL Griffin, B Scheetz, MH High‐Performance Liquid Chromatography Method for Rich Pharmacokinetic Sampling Schemes in Translational Rat Toxicity Models With Vancomycin |
title | High‐Performance Liquid Chromatography Method for Rich Pharmacokinetic Sampling Schemes in Translational Rat Toxicity Models With Vancomycin |
title_full | High‐Performance Liquid Chromatography Method for Rich Pharmacokinetic Sampling Schemes in Translational Rat Toxicity Models With Vancomycin |
title_fullStr | High‐Performance Liquid Chromatography Method for Rich Pharmacokinetic Sampling Schemes in Translational Rat Toxicity Models With Vancomycin |
title_full_unstemmed | High‐Performance Liquid Chromatography Method for Rich Pharmacokinetic Sampling Schemes in Translational Rat Toxicity Models With Vancomycin |
title_short | High‐Performance Liquid Chromatography Method for Rich Pharmacokinetic Sampling Schemes in Translational Rat Toxicity Models With Vancomycin |
title_sort | high‐performance liquid chromatography method for rich pharmacokinetic sampling schemes in translational rat toxicity models with vancomycin |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698807/ https://www.ncbi.nlm.nih.gov/pubmed/28675684 http://dx.doi.org/10.1111/cts.12484 |
work_keys_str_mv | AT joshimd highperformanceliquidchromatographymethodforrichpharmacokineticsamplingschemesintranslationalrattoxicitymodelswithvancomycin AT odonnelljn highperformanceliquidchromatographymethodforrichpharmacokineticsamplingschemesintranslationalrattoxicitymodelswithvancomycin AT venkatesann highperformanceliquidchromatographymethodforrichpharmacokineticsamplingschemesintranslationalrattoxicitymodelswithvancomycin AT changj highperformanceliquidchromatographymethodforrichpharmacokineticsamplingschemesintranslationalrattoxicitymodelswithvancomycin AT nguyenh highperformanceliquidchromatographymethodforrichpharmacokineticsamplingschemesintranslationalrattoxicitymodelswithvancomycin AT rhodesnj highperformanceliquidchromatographymethodforrichpharmacokineticsamplingschemesintranslationalrattoxicitymodelswithvancomycin AT paisg highperformanceliquidchromatographymethodforrichpharmacokineticsamplingschemesintranslationalrattoxicitymodelswithvancomycin AT chapmanrl highperformanceliquidchromatographymethodforrichpharmacokineticsamplingschemesintranslationalrattoxicitymodelswithvancomycin AT griffinb highperformanceliquidchromatographymethodforrichpharmacokineticsamplingschemesintranslationalrattoxicitymodelswithvancomycin AT scheetzmh highperformanceliquidchromatographymethodforrichpharmacokineticsamplingschemesintranslationalrattoxicitymodelswithvancomycin |